INmune Bio, Inc. (INMB) Tops Q2 EPS by 13c

INmune Bio, Inc. (NASDAQ: INMB) reported Q2 EPS of ($0.50), $0.13 better than the analyst estimate of ($0.63).

For earnings history and earnings-related data on INmune Bio, Inc. (INMB) click here.

You May Also Be Interested In

• Active options: NVDA TSLA SPCX MU AAPL INTC CRWV
• Ross Stores (ROST) call put ratio 7.4 calls to 1 put with a focus on August 14 weekly 260 and June 280 calls
• Popular stocks with increasing option volume: SPCX MU INTC CRWV SMCI NBIS HTZ PLTR AMD NOK IREN ORCL MSTR